FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 41 filers reported holding FUSION PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 3,670,516 | $64,124,000 | 12.60% |
| ADAMS STREET PARTNERS LLC | 3,502,425 | $55,069,000 | 11.39% |
| Orbimed Advisors | 3,224,770 | $56,337,000 | 0.79% |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,551,794 | $44,580,000 | 0.79% |
| CLOUGH CAPITAL PARTNERS L P | 402,800 | $7,037,000 | 0.69% |
| ACUTA CAPITAL PARTNERS, LLC | 135,000 | $2,358,000 | 0.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,257,000 | $21,960,000 | 0.64% |
| Perceptive Advisors | 2,235,983 | $35,955,000 | 0.58% |
| Rock Springs Capital Management LP | 937,041 | $16,370,000 | 0.45% |
| Logos Global Management LP | 121,128 | $2,116,000 | 0.42% |